A. Whitton

发表

J. Horsman, W. Furlong, R. Barr, 2015, Journal of pediatric hematology/oncology.

The utility of publicly reported cancer treatment wait time information for patients and health care providers.

A. Jadad, M. Fitch, E. Green, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

Michael I. Seider, W. Curran, B. Movsas, 1997, International journal of radiation oncology, biology, physics.

An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood.

D. Feeny, G. Torrance, W. Furlong, 1993, The American journal of pediatric hematology/oncology.

Accelerated radiation therapy for primary lymphoma of the brain.

C. Wong, M. Milosevic, N. Laperriere, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluation

T. Whelan, A. Swaminath, A. Whitton, 2020, Radiation oncology.

Osteopenia in children surviving brain tumours.

R. Barr, C. Webber, A. Whitton, 1998, European journal of cancer.

Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)

P. Brown, C. Hadjipanayis, C. Jan, 2020 .

Anti‐MAG antibodies

A. Pestronk, A. Kornberg, R. Choksi, 1994, Neurology.

Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy

G. Pond, A. Whitton, J. Greenspoon, 2021, Current oncology.

Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.

J. Buckner, P. Brown, C. Hadjipanayis, 2022, JAMA oncology.

Initial experience with Tc-99m-HM-PAO in the study of brain tumors

V. R. McCready, R. Ott, M. Flower, 2004, European Journal of Nuclear Medicine.

Endocrine disorders following treatment of childhood brain tumours.

H. Bloom, P. Hindmarsh, J. Britton, 1990, British Journal of Cancer.

Radiotherapy for jugulo-tympanic paragangliomas (Glomus jugulare tumours)

A. Whitton, P. Sharma, A. Johnson, 1984, The Journal of Laryngology & Otology.

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

J. Buckner, P. Brown, C. Hadjipanayis, 2017, The Lancet. Oncology.

Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (NCCTG N107C (Alliance)/CEC.3).

J. Buckner, P. Brown, C. Hadjipanayis, 2019, International journal of radiation oncology, biology, physics.

Childhood medulloblastoma in Ontario, 1977-1987: population-based results.

B. Fisher, L. Gaspar, J. McLaughlin, 1996, Medical and pediatric oncology.

The Future Is Now—Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018!

P. Brown, A. Nichol, Jennifer J. Hu, 2018, Front. Oncol..

Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases.

H. Bloom, A. Whitton, H.G.G. Bloom, 1990, International journal of radiation oncology, biology, physics.

Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.

J. Michalski, B. Movsas, C. Scott, 2000, International journal of radiation oncology, biology, physics.

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

J. Buckner, P. Brown, C. Hadjipanayis, 2016 .

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.

H. Bloom, P. Workman, P. Selby, 1988, British Journal of Cancer.

Evaluation of pseudoprogression in patients with glioblastoma.

A. Whitton, S. Parpia, M. Kucharczyk, 2017, Neuro-oncology practice.

Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study

A. Overholt, H. Hirte, A. Whitton, 2014, OncoTargets and therapy.

Health status measurements at diagnosis as predictors of survival among adults with brain tumors.

D. Feeny, W. Furlong, A. Willan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

D. Feeny, W. Furlong, D. Feeny, 1999, European journal of cancer.

Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario.

K Leszczynski, P. Warde, M. Sharpe, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Management of Children with Acute Lymphoblastic Leukemia by the Dana‐Farber Cancer Institute Protocols: An Update of the Ontario Experience

R. Barr, A. Whitton, J. Halton, 1992, The American journal of pediatric hematology/oncology.

Self‐reported comprehensive health status of adult brain tumor patients using the Health Utilities Index

W. Furlong, R. Barr, D. Feeny, 1997, Cancer.

CMET-48. CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5–15 BRAIN METASTASES

P. Brown, W. Mason, K. Ding, 2017 .

Robotic Radiosurgery for the Treatment of 1–3 Brain Metastases: A Pragmatic Application of Cost-Benefit Analysis Using Willingness-To-Pay

Amiram Gafni, James Wright, Jeffrey Noah Greenspoon, 2013, Technology in cancer research & treatment.

Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada

Mark J Dobrow, Anthony Whitton, M. Dobrow, 2011, BMC health services research.

Exploration of Morbidity in a Serial Study of Long-Term Brain Tumor Survivors: A Focus on Pain.

J. Horsman, W. Furlong, R. Barr, 2015, Journal of adolescent and young adult oncology.

Disseminated Langerhans Cell Histiocytosis in Identical Twins Unresponsive to Recombinant Human α‐Interferon and Total Body Irradiation

A. Whitton, J. Halton, R. Barr, 1992, The American journal of pediatric hematology/oncology.

Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3)

J. Buckner, P. Brown, E. Galanis, 2019, International Journal of Radiation Oncology*Biology*Physics.

Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.

H. Bloom, D. Tait, I. Syndikus, 1995, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Surgical Management of Meningiomas Involving the Torcula, Transverse Sinus, and Jugular Bulb: A Technical Note and Review of the Literature

E. Kasper, A. Whitton, Robert G. Power, 2021, Journal of Neurological Surgery Reports.

Phase I study of hyperfractionated whole brain irradiation (HWBI) in the treatment of primary cerebral lymphoma.

C. Catton, P. Davey, A. Whitton, 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

The Technique and Cost of Radiosurgery for the Treatment of 1-3 Brain Metastases

A. Whitton, W. Sharieff, T. Chow, 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Medulloblastoma - Ontario provincial review (1977 – 1987)

B. Fisher, L. Gaspar, C. Danjoux, 1993 .

Self‐reported comprehensive health status of adult brain tumor patients using the Health Utilities Index

W. Furlong, R. Barr, D. Feeny, 1997, Cancer.

Low-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG 0539.

H. Shu, J. D. de Groot, M. Vogelbaum, 2022, Neuro-oncology.